This double-blinded, cluster-randomized trial compared the effects of antenatal iron-folic acid (IFA) and multiple micronutrient supplementation (MMS) on the micronutrient status of newborns in rural Bangladesh. MMS increased newborn ferritin, 25(OH)D, and zinc, while maternal and newborn folate, vitamins B-12, D, and E, zinc, and iodine biomarkers were positively related. Despite the limited effects of MMS, better maternal micronutrient status was associated with improved micronutrient status of Bangladeshi newborns.

This policy brief outlines the cost-effectiveness and investment case in Malawi, Africa, to transition from iron-folic acid (IFAS) to multiple micronutrient supplementation (MMS).

This article outlines the strong evidence that supports multiple micronutrient supplementation (MMS) and argues that implementation should be scaled up rapidly while addressing service delivery barriers.

A  3-arm cluster-randomized trial was conducted that evaluated the efficacy of prenatal multiple micronutrient supplementation (MMS), lipid-based nutrient supplementation (LNS), as compared to routine iron–folic acid (IFA) supplementation among pregnant women in the rural district of Madarounfa, Niger, from March 2015 to August 2019. Results demonstrated that there was no benefit of prenatal MMS on child development outcomes up to 2 years of age as compared to IFA. There was evidence of an apparent positive effect of prenatal LNS on cognitive development trajectory and time to achievement of selected gross motor milestones.

The World Health Organization (WHO) Department of Nutrition for Health and Development, in collaboration with the United Nations Children’s Fund (UNICEF) and Nutrition International (NI), convened a technical consultation “Multiple micronutrient supplements in pregnancy: Implementation considerations for successful incorporation into existing programmes.” The objectives of the technical consultation were to (a) examine implementation experiences of micronutrient supplementation interventions in pregnant women, lessons learned, and best practices; (b) discuss programmatic and technical considerations of interventions on multiple micronutrient supplementation (MMS) in pregnant women in low-, middle-, and high-income countries; and (c) identify implementation considerations that can be useful to scale up efforts by national policymakers and their advisors considering MMS as part of existing antenatal care programs as well as other delivery platforms.  This paper provides the background and rationale of the technical consultation, synopsizes the presentations, and summarizes the primary considerations and conclusions reached during plenary discussions.

The Social Marketing Company (SMC) in Bangladesh is implementing a countrywide, market-based roll-out of multiple micronutrient supplementation (MMS) for pregnant women. This study evaluated the implementation of the supplementation program and its impact on reducing low birth weight (LBW).

 This is an FAQ and Advocacy Brief for the Inclusion of Multiple Micronutrient Supplementation (MMS) into the WHO’s Model List of Essential Medicines to help improve women’s nutrition during pregnancy.

This FAQ brief addresses frequently asked questions on MMS.

This Advocacy Brief is meant to equip champions and decision-makers to advocate for safe, affordable, and cost-effective nutrition interventions, particularly multiple micronutrient supplementation (MMS) to improve maternal health.

This fact sheet provides a complete introduction to the Healthy Mothers Healthy Babies Consortium (HMHB), its origin, activities, and future direction.